Ryan O Emerson

USPTO Granted Patents = 18 (Patent Applications = 8)

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 9 (Patent Applications = 17)

Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 147(Granted Patents)

Company Filing History:

15 out of 56

Adaptive Biotechnologies Corporation

patents

4 out of 289

Fred Hutchinson Cancer Center

patents

3 out of 559

Memorial Sloan Kettering Cancer Center

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12428682 - Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing (2025-09-30),

2. 12230363 - Efficiently characterizing protein-protein interactions (2025-02-18),

3. 12195730 - High-throughput screening methods to identify small molecule targets (2025-01-14),

4. 12104211 - Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization (2024-10-01),

5. 11466265 - High-throughput screening methods to identify small molecule targets (2022-10-11),

6. 11254980 - Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements (2022-02-22),

7. 11248253 - Methods using randomer-containing synthetic molecules (2022-02-15),

8. 11180813 - Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization (2021-11-23),

9. 11066705 - Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing (2021-07-20),

10. 11047008 - Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing (2021-06-29),

11. 10894977 - Compositions and methods for measuring and calibrating amplification bias in multiplexed PCR reactions (2021-01-19),

12. 10392663 - Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from a large number of samples (2019-08-27),

13. 10246701 - Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture (2019-04-02),

14. 10221461 - Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization (2019-03-05),

15. 10214770 - Compositions and method for measuring and calibrating amplification bias in multiplexed PCR reactions (2019-02-26),

Title: Innovations and Contributions of Ryan O Emerson

Introduction

Ryan O Emerson is a prominent inventor based in Seattle, WA (US), known for his significant contributions to the field of immunology and infectious disease diagnostics. With a total of 18 patents to his name, Emerson has made remarkable strides in developing methods that enhance our understanding of immune responses and disease detection.

Latest Patents

Among his latest patents, Emerson has developed methods for diagnosing infectious diseases and determining HLA status using immune repertoire sequencing. These methods predict a subject's infection status by utilizing high-throughput T cell receptor sequencing to match the subject's TCR repertoire with a known set of disease-associated T cell receptor sequences. This innovative approach allows for the prediction of several infectious agents from a single sample. Additionally, he has created methods for predicting a subject's HLA status through high-throughput immune receptor sequencing. Another notable patent focuses on efficiently characterizing protein-protein interactions, providing methods to improve libraries for screening these interactions by excluding amino acid substitutions that minimally affect binding between protein partners.

Career Highlights

Emerson has worked with leading organizations in the biotechnology sector, including Adaptive Biotechnologies Corporation and Fred Hutchinson Cancer Center. His work in these institutions has been pivotal in advancing research and applications in immunology.

Collaborations

Throughout his career, Emerson has collaborated with notable professionals in the field, including Harlan Saul Robins and Anna M Sherwood. These collaborations have further enriched his research and innovations.

Conclusion

Ryan O Emerson's contributions to the field of immunology and infectious disease diagnostics are significant and impactful. His innovative methods and collaborations continue to shape the future of medical research and diagnostics.

This text is generated by artificial intelligence and may not be accurate.